Molecular Pathology of the Genitourinary Tract: Prostate and Bladder

Surgical Pathology Clinics
S Joseph Sirintrapun, Anil V Parwani

Abstract

The knowledge of cellular mechanisms in tumors of the prostate and bladder has grown exponentially. Molecular technologies have led to the discovery of TMPRSS2 in prostate cancer and the molecular pathways distinguishing low- and high-grade urothelial neoplasms. UroVysion with fluorescence in situ hybridization is already commonplace as an adjunct to cytologic diagnosis of urothelial neoplasms. This trend portends the future in which classification and diagnosis of tumors of the prostate and bladder through morphologic analysis will be supplemented by molecular information correlating with prognosis and targeted therapy. This article outlines tumor molecular pathology of the prostate and bladder encompassing current genomic, epigenomic, and proteonomic findings.

References

Jan 1, 1992·Journal of Cellular Biochemistry. Supplement·L G Koss
Aug 19, 1992·Journal of the National Cancer Institute·C J LogothetisW F Benedict
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R BooksteinW H Lee
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R MontesanoL Orci
Oct 18, 1995·Journal of the National Cancer Institute·I OrlowC Cordon-Cardo
Oct 20, 1993·Journal of the National Cancer Institute·N M NavoneC J Conti
May 25, 1995·The New England Journal of Medicine·M E TaplinS P Balk
Feb 1, 1994·The Journal of Urology·H J VoellerE P Gelmann
Nov 10, 1994·The New England Journal of Medicine·D EsrigR J Cote
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·H J XuS X Hu
Aug 21, 1993·Lancet·G DalbagniC Cordon-Cardo
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Jul 1, 1993·Genes & Development·X WuA J Levine
Jul 1, 1993·The Journal of Urology·P J EffertE T Liu
Feb 1, 1996·Genes, Chromosomes & Cancer·J V TricoliR W deVere White
Oct 18, 1996·Cell·K W Kinzler, B Vogelstein
Nov 1, 1996·American Journal of Clinical Pathology·M NagabhushanM S Sy
Jan 9, 1997·Nature·R J CoteD G Skinner
Jan 15, 1997·Journal of the National Cancer Institute·D J GrignonJ D Cox
Aug 28, 1997·Oncogene·J PietteV Maréchal
Jun 6, 1998·Proceedings of the National Academy of Sciences of the United States of America·Y E WhangC L Sawyers
Jul 17, 1998·The American Journal of Pathology·N N NupponenT Visakorpi
Jul 22, 1998·Journal of the National Cancer Institute·J P SteinR J Cote
Oct 6, 1998·Urological Research·T F Orntoft, H Wolf

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.